Compare PGEN & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | KALU |
|---|---|---|
| Founded | 1998 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2013 | 2006 |
| Metric | PGEN | KALU |
|---|---|---|
| Price | $7.02 | $115.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $13.65 | ★ $141.00 |
| AVG Volume (30 Days) | ★ 4.5M | 327.1K |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | ★ 135.89 |
| EPS | 0.03 | ★ 11.26 |
| Revenue | $230,981,000.00 | ★ $1,585,900,000.00 |
| Revenue This Year | $2,335.22 | $39.77 |
| Revenue Next Year | $85.34 | N/A |
| P/E Ratio | $223.17 | ★ $10.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.04 | $88.00 |
| 52 Week High | $8.98 | $199.89 |
| Indicator | PGEN | KALU |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 32.67 |
| Support Level | $6.57 | $105.45 |
| Resistance Level | $7.44 | $154.48 |
| Average True Range (ATR) | 0.42 | 7.11 |
| MACD | -0.03 | -2.60 |
| Stochastic Oscillator | 55.14 | 20.48 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.